Dr Reddys Laboratories RDY
NYSE RDY
$11.85 -0.03 (-0.29%)
As of: Sep 9, 2026 · 2:32 PM EDT

Dr Reddys Laboratories (RDY) Prepaid Assets (2009 - 2026)

Dr Reddys Laboratories (RDY) posted Prepaid Assets of $384.1 million for Q2 2026, down 3.15% on a QoQ basis from $396.6 million in Q1 2026, and up 3.48% year-over-year from $371.2 million in Q2 2025.

Analysis

Dr Reddys Laboratories (RDY) Prepaid Assets (2009 - 2026) Analysis & Trends

Dr Reddys Laboratories has reported Prepaid Assets for 18 years, with the latest figure at $384.1 million in Q2 2026.

  • On a quarterly basis, Prepaid Assets rose 3.48% year-over-year to $384.1 million in Q2 2026; TTM through Jun 2026 was $384.1 million, a 3.48% increase from a year earlier, with the FY2026 full-year figure at $386.0 million, up 9.35% from the prior year.
  • Prepaid Assets was $384.1 million for Q2 2026 at Dr Reddys Laboratories, down from $396.6 million in the prior quarter.
  • The five-year high for Prepaid Assets was $413.1 million in Q3 2025, with the low at $184.9 million in Q1 2022.
  • Average Prepaid Assets over 5 years is $300.1 million, with a median of $287.9 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: Prepaid Assets retreated 7.09% in 2022, then soared 32.05% in 2023.
  • Over 5 years, Prepaid Assets stood at $233.1 million in 2022, then gained by 21.11% to $282.4 million in 2023, then rose by 20.59% to $340.5 million in 2024, then advanced by 7.13% to $364.8 million in 2025, then grew by 5.29% to $384.1 million in 2026.
  • The last three Prepaid Assets figures came in at $384.1 million (Q2 2026), $396.6 million (Q1 2026), and $364.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.63 Bn 38.97 Bn 2.15 Bn
2 Viatris 19.19 Bn 18.30 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn
5 Bausch Health Companies 2.36 Bn 520.30 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 995.52 Mn 705.40 Mn 93.47 Mn
9 Fennec Pharmaceuticals 404.35 Mn 363.10 Mn 17.15 Mn
10 RedHill Biopharma 176.59 Mn 176.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 384.10 Mn
Mar 31, 2026 396.61 Mn
Dec 31, 2025 364.80 Mn
Sep 30, 2025 413.10 Mn
Jun 30, 2025 371.20 Mn
Mar 31, 2025 348.08 Mn
Dec 31, 2024 340.51 Mn
Sep 30, 2024 336.89 Mn
Jun 30, 2024 293.50 Mn
Mar 31, 2024 271.66 Mn
Dec 31, 2023 282.38 Mn
Sep 30, 2023 271.25 Mn
Jun 30, 2023 225.32 Mn
Mar 31, 2023 244.14 Mn
Dec 31, 2022 233.15 Mn
Sep 30, 2022 229.90 Mn
Jun 30, 2022 210.17 Mn
Mar 31, 2022 184.88 Mn
Dec 31, 2021 186.79 Mn
Sep 30, 2021 214.56 Mn